Potential TELA Bio, Inc. (NASDAQ:TELA) shareholders may wish to note that the Co-founder, Antony Koblish, recently bought US$200k worth of stock, paying US$2.25 for each share. That's a very decent purchase to our minds and it grew their holding by a solid 42%.

View our latest analysis for TELA Bio

TELA Bio Insider Transactions Over The Last Year

Notably, that recent purchase by Antony Koblish is the biggest insider purchase of TELA Bio shares that we've seen in the last year. We do like to see buying, but this purchase was made at well below the current price of US$2.86. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.

In the last twelve months TELA Bio insiders were buying shares, but not selling. Their average price was about US$2.52. It is certainly positive to see that insiders have invested their own money in the company. However, we do note that they were buying at significantly lower prices than today's share price. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

TELA Bio is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.

Insider Ownership

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Our data indicates that TELA Bio insiders own about US$5.5m worth of shares (which is 7.8% of the company). We do generally prefer see higher levels of insider ownership.

So What Does This Data Suggest About TELA Bio Insiders?

It's certainly positive to see the recent insider purchases. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss during the last year, which makes us a little cautious. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactions suggests that TELA Bio insiders are expecting a bright future. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing TELA Bio. Every company has risks, and we've spotted 2 warning signs for TELA Bio you should know about.

But note: TELA Bio may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.